EIF2AK2 and arthritic joint disease: [28]) [29], including arthritis, where PKR activation increases production of IL-6 and TNF-α [24,25], and promotes cartilage breakdown and bone remodelling [[34], [35], [36], [37], [38], [39], [40]].